Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-10

Clinical Trial Update: Evaluation of the Effect of Ketamine on Remifentanil-induced Hyperalgesia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether ketamine influences remifentanil-induced hyperalgesia; study completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (Ketalar, Ketanest) (ketamine)
  • Remifentanil (Ultiva) (remifentanil)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Pain, Hyperalgesia | Phase 3 | Status: COMPLETED | Results posted: 2014-11-10